Abstract
BackgroundA routine method for the quantification of beryllium in biological fluids is essential for the development of a chelation therapy for Chronic Beryllium Disease (CBD). We describe a procedure for the direct determination of beryllium in undigested micro quantities of human blood and serum using graphite furnace atomic absorption spectrometry. Blood and serum samples are prepared respectively by a simple 8-fold and 5-fold dilution with a Nash Reagent. Three experimental setups are compared: using no modifier, using magnesium nitrate and using palladium/citric acid as chemical modifiers.ResultsIn serum, both modifiers did not improve the method sensitivity, the optimal pyrolysis and atomization temperatures are 1000°C and 2900°C, respectively. In blood, 6 μg of magnesium nitrate was found to improve the method sensitivity. The optimal pyrolysis and atomization temperatures were 800°C and 2800°C respectively.ConclusionIn serum, the method detection limit was 2 ng l-1, the characteristic mass was 0.22 (± 0.07) pg and the accuracy ranged from 95 to 100%. In blood, the detection limit was 7 ng l-1, the characteristic mass was 0.20 (± 0.02) pg and the accuracy ranged from 99 to 101%.
Highlights
A routine method for the quantification of beryllium in biological fluids is essential for the development of a chelation therapy for Chronic Beryllium Disease (CBD)
We found that the optimal pyrolysis temperature generating the highest beryllium signal was 1000°C
Background signal decreased by 48% when we ramped the pyrolysis temperature from 800 to 900°C but the beryllium absorbance decreased by 10%
Summary
A routine method for the quantification of beryllium in biological fluids is essential for the development of a chelation therapy for Chronic Beryllium Disease (CBD). Beryllium is the 35th most abundant element in the earth's crust, with an average of 6 mg kg-1 [1] It has unique physical and chemical properties that improves the characteristics of alloys producing greater tensile strength, high electrical and thermal conductivity, along with good corrosion and fatigue resistance [2]. Recent molecular epidemiological studies found a significant correlation between the risk of developing CBD and the predicted surface electrostatic potential of the HLA-DP alleles, suggesting that individuals who carry the most negatively charged alleles are at greater risk of beryllium sensitization and CBD [6].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
